Barri Blauvelt

Demonstrating Impact of Upstream Omnichannel Strategy on Downstream Results

by Barri M. Blauvelt, CEO, Innovara Upstream strategy used to be the domain of health care marketing. Today, it involves commercial, clinical research, access management,...

Barri Blauvelt - March 28, 2018

Cytonus expands its Scientific Advisory Board with mRNA expert Michael Houston, PhD

Look Who’s On the Move! March 28, 2023

Switch Therapeutics Expands Leadership Team with Key Appointments

Industry News March 28, 2023

CANbridge Pharmaceuticals CAN008 Phase 2 Trial for Treatment of Glioblastoma Multiforme (GBM) in China Reaches Full Enrollment

Industry News March 28, 2023

Avacta Appoints Karen Harrison as Chief Operating Officer for Therapeutics Division

Look Who’s On the Move! March 28, 2023

Newron Presents Six-Month Interim Data From the First 100 Patients Randomized in Study 014/015 at the 31st European Congress of Psychiatry

Industry News March 28, 2023

Bristol Myers Squibb Receives European Commission Approval of Sotyktu (deucravacitinib), a Once-Daily Oral Treatment for Adults With Moderate-to-Severe Plaque Psoriasis

Editor´s Pick March 28, 2023

Silence Therapeutics Appoints Dr. Steven Romano as Incoming Chief Medical Officer and Head of Research and Development

Look Who’s On the Move! March 28, 2023

Sonoma Biotherapeutics and Regeneron Announce Collaboration to Discover, Develop and Commercialize Treg Cell Therapies for Autoimmune Diseases

Industry News March 28, 2023

Prilenia Achieves Last Patient Last Visit in Phase 3 PROOF-HD Clinical Study for Huntington’s Disease

Industry News March 28, 2023

Simulations Plus Enters New Strategic Collaboration to Discover Anticancer Therapies Through Its AI-Driven Drug Design Technology

Industry News March 28, 2023

Virpax Pharmaceuticals Announces Appointment of Barbara A. Ruskin, Ph.D, J.D. to the Board of Directors

Look Who’s On the Move! March 28, 2023

Andrew Miller Joins Elucid as Chief Technology Officer

Look Who’s On the Move! March 28, 2023

OncoVerity, Inc. Announces Exclusive Worldwide Licensing Rights to Cusatuzumab and Appoints Max Colao as Chief Executive Officer

Regulatory Affairs March 28, 2023

ANANDA Scientific Announces First Patient Enrolled in FDA-approved Clinical Trial Evaluating a Potential New Treatment for Social Anxiety Disorder (SAD)

Regulatory Affairs March 28, 2023

Direct Biologics Announces First Patient Dosed with ExoFlo™ in a Phase 1 Clinical Trial for Medically Refractory Ulcerative Colitis

Industry News March 28, 2023

Barri Blauvelt

Recent Articles